LP
ASMB icon

LMR Partners’s Assembly Biosciences ASMB Stock Holding History

LMR Partners’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,185
Closed -$55K – 993
2021
Q2 		$55K Buy
+1,185
New +$58.7K ﹤0.01% 976
2016
Q3 		– Sell
-1,305
Closed -$87K – 348
2016
Q2 		$87K Buy
+1,305
New +$85.6K 0.01% 409

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

LMR Partners's ASMB Position: Q3 2021 in Review

LMR Partners sold out of Assembly Biosciences (ASMB) in Q3 2021, closing a stake of 1,185 shares — an estimated $55K sold.

LMR Partners first reported a position in ASMB in Q2 2016 and held it in 2 quarters. The position peaked at $87K in Q2 2016. 65 funds tracked by Wall St. Rank hold ASMB as of Q3 2021.

  • LMR Partners reported no remaining Assembly Biosciences position as of Q3 2021 after selling out during the quarter.
  • LMR Partners sold 1,185 Assembly Biosciences shares in Q3 2021, an estimated $55K.
  • LMR Partners first reported a position in Assembly Biosciences in Q2 2016 and held it in 2 quarters.
  • LMR Partners's Assembly Biosciences position peaked at $87K in Q2 2016.
  • 65 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2021.

Based on LMR Partners's 13F filing for Q3 2021, filed 15 Nov 2021.